Publications by authors named "Neus Baste"

Claim this Profile
C
Cancer stem cell biomarkers in locally advanced head and neck squamous cell carcinoma.
Miguel Caballero-Borrego, Juan J Grau, Neus Basté, Paola C Castillo, Cristina Teixido

Braz J Otorhinolaryngol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study.
Javier García-Corbacho, Alberto Indacochea, Iván Victoria, Débora Moreno, Laura Angelats

Cancer Immunol Immunother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023).
Teresa Alonso-Gordoa, Paula Jimenez-Fonseca, Javier Martinez-Trufero, Miguel Navarro, Ignacio Porras

Clin Transl Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Javier García-Corbacho, Alberto Indacochea, Azucena E González Navarro, Iván Victoria, Débora Moreno

Cancer Immunol Immunother· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making.
Alfredo Páez-Carpio, Santiago Medrano-Martorell, Joan Berenguer, Africa Muxí, Isabel Vilaseca, Neus Baste

Eur Arch Otorhinolaryngol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Kevin J Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CO-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy.
Isabel Vilaseca, Francesc Xavier Avilés-Jurado, Eduardo Lehrer, Izaskun Valduvieco, Neus Baste

Oral Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
Barbara Burtness, Danny Rischin, Richard Greil, Denis Soulières, Makoto Tahara

J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.
Carlos Gomez-Roca, Caroline Even, Christophe Le Tourneau, Neus Basté, Jean-Pierre Delord

Clin Transl Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
Isabel Vilaseca, Francesc Xavier Aviles-Jurado, Izaskun Valduvieco, Joan Berenguer, Juan José Grau, Neus Baste

Head Neck· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck.
Khalil Saleh, Anne Auperin, Nicolas Martin, Edith Borcoman, Nouritza Torossian, Neus Baste

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study.
Rebecca Kristeleit, Victor Moreno, Valentina Boni, Eva M Guerra, Carmen Kahatt

Int J Gynecol Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging systemic antitarget treatment for differentiated thyroid carcinoma.
Neus Basté, Mireia Mora, Juan José Grau

Curr Opin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker.
Ximena Terra, Victoria Ceperuelo-Mallafré, Carla Merma, Ester Benaiges, Ramon Bosch

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
Ruth Gabriela Herrera Gómez, Khalil Saleh, Lamia Mayache, Mariana Iacob, Neus Baste

Oral Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy combinations for the treatment of patients with solid tumors.
Maria Virginia Bluthgen, Neus Basté, Gonzalo Recondo

Future Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Sara I Pai, Ezra E W Cohen, Derrick Lin, George Fountzilas, Edward S Kim, Neus Baste

J Transl Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara

Lancet· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approaches in salivary gland carcinoma.
Caroline Even, Neus Baste, Marion Classe

Curr Opin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Treatment Recommendations by Molecular Tumor Boards Worldwide.
Damian T Rieke, Mario Lamping, Marissa Schuh, Christophe Le Tourneau, Neus Basté

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis